Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.230
-0.050 (-3.91%)
At close: Apr 28, 2026, 4:00 PM EDT
1.260
+0.030 (2.44%)
After-hours: Apr 28, 2026, 7:14 PM EDT

Pulmonx Statistics

Total Valuation

Pulmonx has a market cap or net worth of $51.95 million. The enterprise value is $39.41 million.

Market Cap 51.95M
Enterprise Value 39.41M

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026, after market close.

Earnings Date Apr 29, 2026
Ex-Dividend Date n/a

Share Statistics

Pulmonx has 42.24 million shares outstanding. The number of shares has increased by 4.03% in one year.

Current Share Class 42.24M
Shares Outstanding 42.24M
Shares Change (YoY) +4.03%
Shares Change (QoQ) +1.14%
Owned by Insiders (%) 5.16%
Owned by Institutions (%) 74.04%
Float 37.39M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.58
Forward PS 0.57
PB Ratio 0.99
P/TBV Ratio 1.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.44
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.07, with a Debt / Equity ratio of 1.04.

Current Ratio 5.07
Quick Ratio 4.11
Debt / Equity 1.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -17.01

Financial Efficiency

Return on equity (ROE) is -77.19% and return on invested capital (ROIC) is -26.54%.

Return on Equity (ROE) -77.19%
Return on Assets (ROA) -22.96%
Return on Invested Capital (ROIC) -26.54%
Return on Capital Employed (ROCE) -49.13%
Weighted Average Cost of Capital (WACC) 4.84%
Revenue Per Employee $305,733
Profits Per Employee -$182,443
Employee Count 296
Asset Turnover 0.62
Inventory Turnover 1.43

Taxes

In the past 12 months, Pulmonx has paid $626,000 in taxes.

Income Tax 626,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -76.25% in the last 52 weeks. The beta is 0.19, so Pulmonx's price volatility has been lower than the market average.

Beta (5Y) 0.19
52-Week Price Change -76.25%
50-Day Moving Average 1.45
200-Day Moving Average 1.79
Relative Strength Index (RSI) 38.03
Average Volume (20 Days) 301,680

Short Selling Information

The latest short interest is 2.81 million, so 6.66% of the outstanding shares have been sold short.

Short Interest 2.81M
Short Previous Month 2.86M
Short % of Shares Out 6.66%
Short % of Float 7.53%
Short Ratio (days to cover) 7.04

Income Statement

In the last 12 months, Pulmonx had revenue of $90.50 million and -$54.00 million in losses. Loss per share was -$1.33.

Revenue 90.50M
Gross Profit 67.14M
Operating Income -53.66M
Pretax Income -53.38M
Net Income -54.00M
EBITDA -52.61M
EBIT -53.66M
Loss Per Share -$1.33
Full Income Statement

Balance Sheet

The company has $69.75 million in cash and $56.36 million in debt, giving a net cash position of $13.39 million or $0.32 per share.

Cash & Cash Equivalents 69.75M
Total Debt 56.36M
Net Cash 13.39M
Net Cash Per Share $0.32
Equity (Book Value) 54.12M
Book Value Per Share 1.30
Working Capital 81.63M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.38 million and capital expenditures -$452,000, giving a free cash flow of -$32.83 million.

Operating Cash Flow -32.38M
Capital Expenditures -452,000
Depreciation & Amortization 1.05M
Net Borrowing -100,000
Free Cash Flow -32.83M
FCF Per Share -$0.78
Full Cash Flow Statement

Margins

Gross margin is 74.19%, with operating and profit margins of -59.30% and -59.67%.

Gross Margin 74.19%
Operating Margin -59.30%
Pretax Margin -58.98%
Profit Margin -59.67%
EBITDA Margin -58.13%
EBIT Margin -59.30%
FCF Margin n/a

Dividends & Yields

Pulmonx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.03%
Shareholder Yield -4.03%
Earnings Yield -102.29%
FCF Yield -62.18%

Analyst Forecast

The average price target for Pulmonx is $5.38, which is 337.40% higher than the current price. The consensus rating is "Buy".

Price Target $5.38
Price Target Difference 337.40%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (5Y) 32.90%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Pulmonx has an Altman Z-Score of -4.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.38
Piotroski F-Score 3